We demonstrated that miR-93 promoted HCC cell proliferation, migration and invasion through activation of the oncogenic c-Met/PI3K/Akt pathway, and also inhibited apoptosis and drug-sensitivity by directly inhibiting PTEN and CDKN1A expression in HCC cells. The gene discussed is CDKN1A; the disease is hepatocellular carcinoma.